Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
UBS
Argus Health
Covington
Dow
Chubb
Merck
Accenture
Boehringer Ingelheim

Generated: August 18, 2018

DrugPatentWatch Database Preview

AN-SULFUR COLLOID Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover An-sulfur Colloid, and when can generic versions of An-sulfur Colloid launch?

An-sulfur Colloid is a drug marketed by Pharmalucence and is included in one NDA.

The generic ingredient in AN-SULFUR COLLOID is technetium tc-99m sulfur colloid kit. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the technetium tc-99m sulfur colloid kit profile page.

Summary for AN-SULFUR COLLOID
Drug patent expirations by year for AN-SULFUR COLLOID
Generic Entry Opportunity Date for AN-SULFUR COLLOID
Generic Entry Date for AN-SULFUR COLLOID*:
Constraining patent/regulatory exclusivity:
LOCALIZATION OF LYMPH NODES DRAINING A PRIMARY TUMOR IN PATIENTS WITH MELANOMA WHEN USED WITH A HAND-HELD GAMMA COUNTER
NDA:
Dosage:
SOLUTION;INJECTION, ORAL

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

US Patents and Regulatory Information for AN-SULFUR COLLOID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmalucence AN-SULFUR COLLOID technetium tc-99m sulfur colloid kit SOLUTION;INJECTION, ORAL 017858-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Cipla
Colorcon
Merck
Johnson and Johnson
Fish and Richardson
Fuji
Farmers Insurance
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.